Dr Reddy Laboratories : Book Closure for Dividend and Annual General Meeting – 2021
May 20, 2021 at 01:24 am EDT
Share
•••
Dr.Reddy's �;•
May 19, 2021
BSE Limited
National Stock Exchange of India Limited
New York Stock Exchange Inc.
NSE IFSC Limited
National Securities Depository Ltd.
Central Depository Services (I) Ltd.
J P Morgan Chase Bank
Dr. Raddy's Laboratories Ltd.
8-2-337, Road No. 3, Banjara Hills,
Hyderabad - 500 034, Telangana,
India.
CIN: L85195TG1984PLC004507
Tel
:+91 40 4900 2900
Fax
:+91 40 4900 2999
Email :mail@drreddys.com www.drreddys.com
Sub: Intimation of date of Annual General Meeting and Book Closure pursuant to Section 91 of the Companies Act, 2013 and Regulation 42 of the Securities & Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Pursuant to Section 91 of the Companies Act, 2013 and rules made thereunder and Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements), 2015, the Register of Members and Share Transfer Books of the Company will remain closed from Tuesday, July 13, 2021 to Thursday, July 15, 2021 (both days inclusive) for taking record of the shareholders ofthe Company for the purpose ofAnnual General Meeting of the Company and for determining the shareholders who would be entitled for the payment of dividend, if, declared at the forthcoming Annual General Meeting, scheduled to be held on Wednesday, July 28, 2021.
Symbol
Typeof
Book Closure
Record
Purpose
security
(both dates inclusive)
Date
Equity
From
To
a) Annual General
BSE- 500124
Tuesday,
Thursday,
NA
NSE - DRREDDY
July 13,
July 15,
Meeting
NYSE-RDY
2021
2021
b) Declaration of
NSE IFSC - DRREDDY
final Dividend
This is for your information and records.
With regards,
Bigshare Services Pvt. Ltd. Hyderabad/ Mumbai
Attachments
Original document
Permalink
Disclaimer
Dr. Reddy's Laboratories Limited published this content on 20 May 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 May 2021 05:23:02 UTC.
Dr. Reddy's Laboratories specializes in developing, producing, and selling pharmaceutical products. Net sales break down by activity as follows:
- sales of generic medications (79.9%): brand-name or generic prescription medications and OTC medicines;
- sales of active ingredients (15.7%). The group also supplies customized pharmaceutical services;
- other (4.4%): sales of generic biopharmaceutical products, development of molecular agents, etc.
Net sales are distributed geographically as follows: India (18.8%), the United States (45%), Russia (9.9%) and other (26.3%).
DR. REDDY'S LABORATORIES LIMITED 
